Suparma Tbk PT (SPMA.JK) Stock Price

Suparma Tbk PT Price

CLOSED
164.00IDR-3.00 (-1.81 %)
Market closed

Over the last 19 years Suparma Tbk PT grew revenue by 7.5% annually, reaching 2.74 T IDR. Earnings per share have grown at 1.5% per year over the last 11 years. For Suparma Tbk PT, the net margin of 3.9% is down versus 10.5% a few years ago. At today's price the dividend yield works out to roughly 7.32%. The payout ratio is around 21% of earnings. The dividend has grown at 3.4% per year over the past 12 years. The stock trades about 12% above its 52-week low.

Suparma Tbk PT stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Suparma Tbk PT over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Suparma Tbk PT stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Suparma Tbk PT's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Suparma Tbk PT Stock Price History
DateSuparma Tbk PT Price
8/19/2026164.00 IDR
8/18/2026167.00 IDR
8/14/2026166.00 IDR
8/13/2026164.00 IDR
8/12/2026163.00 IDR
8/11/2026165.00 IDR
8/10/2026164.00 IDR
8/7/2026164.00 IDR
8/6/2026164.00 IDR
8/5/2026164.00 IDR
8/4/2026162.00 IDR
8/3/2026162.00 IDR
7/31/2026163.00 IDR
7/30/2026165.00 IDR
7/29/2026166.00 IDR
7/28/2026169.00 IDR
7/27/2026168.00 IDR
7/24/2026171.00 IDR
7/23/2026169.00 IDR
7/22/2026170.00 IDR
7/21/2026172.00 IDR
7/20/2026171.00 IDR
7/17/2026169.00 IDR
7/16/2026168.00 IDR
7/15/2026168.00 IDR
7/14/2026170.00 IDR
7/13/2026170.00 IDR
7/10/2026172.00 IDR
7/9/2026168.00 IDR
7/8/2026170.77 IDR
7/7/2026167.69 IDR
7/6/2026163.08 IDR
7/3/2026160.00 IDR
7/2/2026158.46 IDR
7/1/2026156.92 IDR
6/30/2026158.46 IDR
6/29/2026155.38 IDR
6/26/2026155.38 IDR
6/25/2026156.92 IDR
6/24/2026156.92 IDR
6/23/2026158.46 IDR
6/22/2026160.00 IDR
6/19/2026160.00 IDR
6/18/2026156.92 IDR
6/17/2026156.92 IDR
6/15/2026160.00 IDR
6/12/2026158.46 IDR
6/11/2026153.08 IDR
6/10/2026151.54 IDR
6/9/2026149.23 IDR
6/8/2026146.15 IDR
6/5/2026150.77 IDR
6/4/2026152.31 IDR
6/3/2026153.85 IDR
6/2/2026160.00 IDR
5/29/2026160.00 IDR
5/28/2026161.54 IDR
5/27/2026161.54 IDR
5/26/2026161.54 IDR
5/25/2026163.08 IDR
5/22/2026155.38 IDR
5/21/2026158.46 IDR
5/20/2026153.85 IDR
5/19/2026158.46 IDR
5/18/2026160.00 IDR
5/15/2026161.54 IDR
5/14/2026161.54 IDR
5/13/2026161.54 IDR
5/12/2026163.08 IDR
5/11/2026163.08 IDR
5/8/2026163.08 IDR
5/7/2026163.08 IDR
5/6/2026163.08 IDR
5/5/2026160.00 IDR
5/4/2026160.00 IDR
4/30/2026161.54 IDR
4/29/2026161.54 IDR
4/28/2026166.15 IDR
4/27/2026167.69 IDR
4/24/2026163.08 IDR
4/23/2026172.31 IDR
4/22/2026170.77 IDR
4/21/2026169.23 IDR
4/20/2026172.31 IDR
4/17/2026173.85 IDR
4/16/2026172.31 IDR
4/15/2026170.77 IDR
4/14/2026170.77 IDR
4/13/2026169.23 IDR
4/10/2026169.23 IDR
4/9/2026167.69 IDR
4/8/2026167.69 IDR
4/7/2026158.46 IDR
4/6/2026160.00 IDR
4/2/2026163.08 IDR
4/1/2026163.08 IDR
3/31/2026160.00 IDR
3/30/2026161.54 IDR
3/27/2026161.54 IDR
3/26/2026161.54 IDR
3/25/2026164.62 IDR
3/17/2026158.46 IDR
3/16/2026158.46 IDR
3/13/2026160.00 IDR
3/12/2026164.62 IDR
3/11/2026164.62 IDR
3/10/2026163.08 IDR
3/9/2026164.62 IDR
3/6/2026166.15 IDR
3/5/2026166.15 IDR
3/4/2026164.62 IDR
3/3/2026175.38 IDR
3/2/2026172.31 IDR
2/27/2026175.38 IDR
2/26/2026176.92 IDR
2/25/2026183.08 IDR
2/24/2026176.92 IDR
2/23/2026176.92 IDR
2/20/2026172.31 IDR
2/19/2026172.31 IDR
2/18/2026178.46 IDR
2/13/2026178.46 IDR
2/12/2026180.00 IDR
2/11/2026175.38 IDR
2/10/2026175.38 IDR
2/9/2026173.85 IDR
2/6/2026173.85 IDR
2/5/2026180.00 IDR
2/4/2026173.85 IDR
2/3/2026178.46 IDR
2/2/2026173.85 IDR
1/30/2026181.54 IDR
1/29/2026176.92 IDR
1/28/2026183.08 IDR
1/27/2026193.85 IDR
1/26/2026189.23 IDR
1/23/2026186.15 IDR
1/22/2026187.69 IDR
1/21/2026184.62 IDR
1/20/2026187.69 IDR
1/19/2026189.23 IDR
1/15/2026186.15 IDR
1/14/2026187.69 IDR
1/13/2026186.15 IDR
1/12/2026184.62 IDR
1/9/2026187.69 IDR
1/8/2026186.15 IDR
1/7/2026189.23 IDR
1/6/2026186.15 IDR
1/5/2026189.23 IDR
1/2/2026187.69 IDR
12/30/2025184.62 IDR
12/29/2025183.08 IDR
12/24/2025183.08 IDR
12/23/2025184.62 IDR
12/22/2025183.08 IDR
12/19/2025187.69 IDR
12/18/2025192.31 IDR
12/17/2025192.31 IDR
12/16/2025181.54 IDR
12/15/2025180.00 IDR
12/12/2025180.00 IDR
12/11/2025180.00 IDR
12/10/2025183.08 IDR
12/9/2025184.62 IDR
12/8/2025187.69 IDR
12/5/2025184.62 IDR
12/4/2025184.62 IDR
12/3/2025184.62 IDR
12/2/2025186.15 IDR
12/1/2025189.23 IDR
11/28/2025190.77 IDR
11/27/2025195.38 IDR
11/26/2025186.15 IDR
11/25/2025190.77 IDR
11/24/2025201.54 IDR
11/21/2025201.54 IDR
11/20/2025203.08 IDR
11/19/2025201.54 IDR
11/18/2025201.54 IDR
11/17/2025201.54 IDR
11/14/2025206.15 IDR
11/13/2025209.23 IDR
11/12/2025213.85 IDR
11/11/2025216.92 IDR
11/10/2025209.23 IDR
11/7/2025217.75 IDR
11/6/2025218.93 IDR
11/5/2025218.93 IDR
11/4/2025217.75 IDR
11/3/2025218.93 IDR
10/31/2025216.57 IDR
10/30/2025217.75 IDR
10/29/2025224.85 IDR
10/28/2025222.49 IDR
10/27/2025227.22 IDR
10/24/2025224.85 IDR
10/23/2025227.22 IDR
10/22/2025211.83 IDR
10/21/2025207.10 IDR
10/20/2025205.92 IDR
10/17/2025205.92 IDR
10/16/2025208.28 IDR
10/15/2025201.18 IDR
10/14/2025207.10 IDR
10/13/2025215.38 IDR
10/10/2025210.65 IDR
10/9/2025210.65 IDR
10/8/2025201.18 IDR
10/7/2025197.63 IDR
10/6/2025198.82 IDR
10/3/2025196.45 IDR
10/2/2025197.63 IDR
10/1/2025195.27 IDR
9/30/2025204.73 IDR
9/29/2025207.10 IDR
9/26/2025215.38 IDR
9/25/2025221.30 IDR
9/24/2025223.67 IDR
9/23/2025213.02 IDR
9/22/2025170.41 IDR
9/19/2025166.86 IDR
9/18/2025166.86 IDR
9/17/2025169.23 IDR
9/16/2025168.05 IDR
9/15/2025170.41 IDR
9/12/2025168.05 IDR
9/11/2025169.23 IDR
9/10/2025170.41 IDR
9/9/2025165.68 IDR
9/8/2025171.60 IDR
9/4/2025172.78 IDR
9/3/2025173.96 IDR
9/2/2025171.60 IDR
9/1/2025169.23 IDR
8/29/2025171.60 IDR
8/28/2025175.15 IDR
8/27/2025171.60 IDR
8/26/2025175.15 IDR
8/25/2025175.15 IDR
Access this data via the Eulerpool API
Get Free API Key

Suparma Tbk PT Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
2.39 T IDR
208.48 B IDR
82.23 B IDR
Jan 1, 2019
2.51 T IDR
188.89 B IDR
131.01 B IDR
Jan 1, 2020
2.15 T IDR
232.54 B IDR
162.52 B IDR
Jan 1, 2021
2.79 T IDR
413.02 B IDR
294.33 B IDR
Jan 1, 2022
3.14 T IDR
464.48 B IDR
336.14 B IDR
Jan 1, 2023
2.66 T IDR
255.06 B IDR
178.66 B IDR
Jan 1, 2024
2.73 T IDR
190.34 B IDR
104.84 B IDR
Jan 1, 2025
2.74 T IDR
197.90 B IDR
106.23 B IDR

Suparma Tbk PT Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 22, 2026, 2:35 PM
 
REVENUET IDR
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB IDR
EBITB IDR
EBIT MARGIN%
NET INCOMEB IDR
NET INCOME GROWTH%
DIV.IDR
SHARESB
2010201120122013201420152016201720182019202020212022202320242025
1.161.191.271.401.551.621.932.092.392.512.152.793.142.662.732.74
14.012.317.179.5011.104.5619.178.3214.155.23-14.4229.8812.30-15.282.680.41
36.6235.8033.4016.6616.4615.2915.9014.8615.4514.7718.1021.0822.9017.5515.1215.54
425.79425.79425.79232.56255.23247.98307.18311.01369.21371.36389.52589.16718.76466.44412.85425.79
109.6994.56129.99137.59141.67117.48156.37173.16208.48188.89232.54413.02464.49255.06190.34197.90
9.437.9510.209.869.147.258.098.278.737.5110.8114.7814.809.596.977.22
29.6233.0839.89-23.8648.96-42.6081.0692.2882.23131.01162.53294.33336.14178.66104.84106.23
9.9811.6720.61-159.80-305.24-187.00-290.3013.84-10.8959.3124.0681.1014.21-46.85-41.321.33
––8.00––––––––15.00––12.00–
4.104.104.102.232.232.232.393.153.152.103.152.953.153.153.154.10
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Suparma Tbk PT generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Suparma Tbk PT retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Suparma Tbk PT's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Suparma Tbk PT has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Suparma Tbk PT's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Suparma Tbk PT stock margins

The Suparma Tbk PT margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Suparma Tbk PT. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Suparma Tbk PT.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
15.45 %
8.73 %
3.44 %
Jan 1, 2019
14.77 %
7.51 %
5.21 %
Jan 1, 2020
18.10 %
10.81 %
7.55 %
Jan 1, 2021
21.08 %
14.78 %
10.53 %
Jan 1, 2022
22.90 %
14.80 %
10.71 %
Jan 1, 2023
17.55 %
9.59 %
6.72 %
Jan 1, 2024
15.12 %
6.97 %
3.84 %
Jan 1, 2025
15.54 %
7.22 %
3.88 %

Suparma Tbk PT Stock Revenue, EBIT, Earnings per Share

The Suparma Tbk PT earnings per share therefore indicates how much revenue Suparma Tbk PT has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2018
757.51 IDR
66.10 IDR
26.07 IDR
Jan 1, 2019
1,200.07 IDR
90.16 IDR
62.53 IDR
Jan 1, 2020
682.13 IDR
73.73 IDR
51.53 IDR
Jan 1, 2021
946.56 IDR
139.90 IDR
99.70 IDR
Jan 1, 2022
994.92 IDR
147.26 IDR
106.57 IDR
Jan 1, 2023
842.88 IDR
80.87 IDR
56.64 IDR
Jan 1, 2024
865.43 IDR
60.35 IDR
33.24 IDR
Jan 1, 2025
668.42 IDR
48.27 IDR
25.91 IDR

Suparma Tbk PT business model & stock analysis

The Indonesian company Suparma Tbk PT has a history of over 4 decades. It was founded in 1976 and has since become one of the largest paper bag manufacturers in the country. The company's business model is primarily based on the production and distribution of paper bags and packaging. They produce various types of paper bags, such as carrier bags, takeaway boxes, and food packaging, using both recycled and new paper. Another important aspect of Suparma Tbk PT is the production of Kraftliner and Testliner papers, which are used for packaging and cardboard manufacturing. The company uses modern machines and high-quality standards to provide the best possible quality to its customers. Suparma Tbk PT is also active in the field of renewable energy, operating a biogas plant in one of its factories since 2018. This enables them to convert waste from paper production into energy and contribute to environmental sustainability. The products of Suparma Tbk PT are distributed both domestically and internationally, and the company is able to offer customized solutions to meet the growing demand for environmentally friendly packaging and products. Overall, Suparma Tbk PT is a company with a diversified business model, active not only in the production of paper bags and packaging but also in other areas. They have a strong focus on sustainability and environmental protection, which is highly commendable considering the global challenges in this field.

Suparma Tbk PT SWOT Analysis

Strengths

  • Established company with a long history in the paper manufacturing industry.
  • Strong brand recognition and reputation in the market.
  • Diverse product portfolio catering to various customer needs.

Weaknesses

  • Reliance on raw material suppliers for paper production.
  • Limited global presence compared to competitors.
  • High energy costs impacting profitability.

Opportunities

  • Growing demand for eco-friendly and sustainable paper products.
  • Expansion into emerging markets with untapped potential.
  • Innovative product development to cater to changing consumer preferences.

Threats

  • Intense competition from both local and international paper manufacturers.
  • Fluctuating raw material prices affecting production costs.
  • Increasing environmental regulations and sustainability standards.

Suparma Tbk PT Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Suparma Tbk PT historical P/E ratio, EBIT multiple, and P/S ratio

Suparma Tbk PT annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Suparma Tbk PT shares outstanding

The number of shares of Suparma Tbk PT was 4.1 B in 2025. This indicates how many shares Suparma Tbk PT is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2018
3.15 B Stocks
Jan 1, 2019
2.10 B Stocks
Jan 1, 2020
3.15 B Stocks
Jan 1, 2021
2.95 B Stocks
Jan 1, 2022
3.15 B Stocks
Jan 1, 2023
3.15 B Stocks
Jan 1, 2024
3.15 B Stocks
Jan 1, 2025
4.10 B Stocks

Suparma Tbk PT stock splits

In Suparma Tbk PT's history, there have been no stock splits.

Suparma Tbk PT Dividend History

7 years of dividend payments

YearAnnual DividendYoY ChangePayments
202412.00IDR↓ 20.0%1×
202115.00IDR↑ 87.5%1×
20128.00IDR↑ 33.3%1×
20006.00IDR↓ 40.0%1×
199710.00IDR↓ 50.0%1×
199620.00IDR↓ 66.7%1×
199560.00IDR—1×

Suparma Tbk PT dividend payout ratio

In 2025, Suparma Tbk PT had a payout ratio of 16.23%. The payout ratio indicates the percentage of the company's profits that Suparma Tbk PT distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2018
13.67 %
Jan 1, 2019
13.67 %
Jan 1, 2020
13.67 %
Jan 1, 2021
5.97 %
Jan 1, 2022
13.67 %
Jan 1, 2023
13.67 %
Jan 1, 2024
21.36 %
Jan 1, 2025
16.23 %
Price targets and forecasts for Suparma Tbk PT are not yet available.

Suparma Tbk PT shareholder structure

% Name
49.98254%
PT Pacific Star Synergy
PT Pacific Star Synergy
31.48159%
PT Gloriajaya Gempita
PT Gloriajaya Gempita
10.67609%
PT Graha Inti Harapan
PT Graha Inti Harapan
0.11858%
Cathay Utima Investment Pte Ltd
Cathay Utima Investment Pte Ltd
0.03465%
Niche Asset Management Limited
Niche Asset Management Limited

Suparma Tbk PT Beneficial Ownership Filings (SEC 13D/G)

Free Float
6.6%
Float Shares
-
Shares Outstanding
-

Suparma Tbk PT Executives and Management Board

8 members · avg. age 57 · 13 % women

Management

.W

Mr. .. Welly (74)

President Commissioner · since 1994

–
ES

Mr. Edward Sopanan (44)

President Director

–
TJ

Mr. Tan Juanto (66)

Independent Commissioner

–
ML

Ms. M.B. Lanniwati (63)

Independent Commissioner · since 2005

–
.S

Mr. .. Subiantara (66)

Independent Commissioner

–

Board of Directors

BL

Mr. Barli Leoponco (41)

Director · since 2020

–
JS

Mr. Joseph Sulaiman (42)

Director · since 2005

–
HL

Mr. Hendro Luhur (56)

Independent Director, Corporate Secretary

–

Frequently asked questions about Suparma Tbk PT

The business model of Suparma Tbk PT revolves around the production and distribution of various paper products. As a leading paper manufacturer in Indonesia, Suparma Tbk PT specializes in producing high-quality paper, including tissue paper, packaging paper, and specialty paper products. The company operates with a vertically integrated approach, encompassing the sourcing of raw materials, manufacturing processes, and delivery to customers. Through continuous innovation and commitment to quality, Suparma Tbk PT aims to meet the diverse needs of its customers while maintaining environmental sustainability. With its strong market presence and robust production capabilities, Suparma Tbk PT strives to be a trusted and reliable provider of paper solutions in the industry.

Suparma Tbk PT is primarily active in the paper and packaging industry.

The main competitors of Suparma Tbk PT in the market include other prominent paper manufacturing companies such as Asia Pulp & Paper Co. Ltd, PT Indah Kiat Pulp & Paper Tbk, and PT Pabrik Kertas Tjiwi Kimia Tbk. These competitors operate within the same industry and offer similar products and services. Their presence and competition contribute to shaping Suparma Tbk PT's market position and drive the company to continuously innovate and differentiate itself in order to maintain a competitive edge.

Suparma Tbk PT, established in 1976, is a reputable Indonesian company specializing in paper manufacturing. With a rich history spanning over four decades, Suparma Tbk PT has grown into one of the leading producers of high-quality paper products in the country. The company focuses on producing uncoated woodfree paper, which is widely used for various purposes such as printing books, magazines, and stationery. Suparma Tbk PT has garnered a strong market presence, serving both domestic and international customers. With a commitment to innovation and sustainability, Suparma Tbk PT continues to thrive in the paper industry, contributing to economic growth and environmental preservation.

Suparma Tbk PT has achieved several significant milestones throughout its history. One notable milestone was its establishment in 1976 as a leading paper and stationery manufacturer in Indonesia. Over the years, the company has expanded its product portfolio and diversified its business segments, becoming a trusted name in the industry. In 2001, Suparma Tbk PT went public and successfully listed its shares on the Indonesia Stock Exchange (IDX), marking a major milestone in its corporate journey. With a strong commitment to innovation, quality assurance, and sustainable practices, Suparma Tbk PT continues to thrive and deliver value to its stakeholders.

Suparma Tbk PT is primarily present in Indonesia.

Suparma Tbk PT represents values of integrity, innovation, and customer satisfaction. The company's corporate philosophy focuses on delivering high-quality products and services to meet the needs of its customers. Suparma Tbk PT strives to continuously innovate and improve its processes to stay ahead in the competitive market. With a strong emphasis on integrity, the company aims to operate ethically and maintain transparent business practices. Through its commitment to excellence and customer-centric approach, Suparma Tbk PT establishes itself as a reliable and trusted provider in the industry.

Converted at the current exchange rate, the Suparma Tbk PT share trades at 0.01 EUR (164.00 IDR).

Suparma Tbk PT is a leading company in the paper industry in Indonesia and one of the largest in Asia. The company was established in 1976 and is based in Surabaya, Indonesia. Suparma Tbk PT is a vertically integrated company that serves various sectors, including the production of paper products, tissues, and packaging. Answer: Suparma Tbk PT is a leading company in the paper industry in Indonesia and one of the largest in Asia. It was established in 1976 and is based in Surabaya, Indonesia. The company serves various sectors, including the production of paper products, tissues, and packaging.

The revenue cannot currently be calculated for Suparma Tbk PT.

The profit cannot currently be calculated for Suparma Tbk PT.

The P/E ratio cannot be calculated for Suparma Tbk PT at the moment.

The P/S cannot be calculated for Suparma Tbk PT currently.

The Eulerpool Quality Score for Suparma Tbk PT is 4/10.

The ISIN of Suparma Tbk PT is ID1000054307. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Suparma Tbk PT is SPMA.JK. The ticker symbol is used to trade Suparma Tbk PT shares on the stock exchange.

Over the past 12 months, Suparma Tbk PT paid a dividend of 12.00 IDR . This corresponds to a dividend yield of about 7.32 %. For the coming 12 months, Suparma Tbk PT is expected to pay a dividend of 7.10 IDR.

The current dividend yield of Suparma Tbk PT is 7.32 %.

Suparma Tbk PT pays a dividend, distributed in the months of , , , .

Suparma Tbk PT paid dividends every year for the past 0 years.

For the upcoming 12 months, dividends amounting to 7.10 IDR are expected. This corresponds to a dividend yield of 4.33 %.

Suparma Tbk PT is assigned to the 'Commodities' sector.

To receive the latest dividend of Suparma Tbk PT from amounting to 12 IDR, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

The dividends of Suparma Tbk PT are distributed in IDR.

All fundamentals and in-depth analysis of Suparma Tbk PT

Our stock analysis for Suparma Tbk PT stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Suparma Tbk PT. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Suparma Tbk PT Stock
Suparma Tbk PT Revenue→
Suparma Tbk PT Stock
Suparma Tbk PT Net Income→
Suparma Tbk PT Stock
Suparma Tbk PT P/E→
Suparma Tbk PT Stock
Suparma Tbk PT P/S→
Suparma Tbk PT Stock
Suparma Tbk PT EBIT→
Suparma Tbk PT Stock
Suparma Tbk PT Dividend→
Suparma Tbk PT Stock
Suparma Tbk PT Directors Dealings→
Suparma Tbk PT Stock
Suparma Tbk PT Stocks→
Suparma Tbk PT Stock
Suparma Tbk PT Market capitalization→
Suparma Tbk PT Stock
Suparma Tbk PT Debt→
Suparma Tbk PT Stock
Suparma Tbk PT Liabilities→
Suparma Tbk PT Stock
Suparma Tbk PT Equity→
Suparma Tbk PT Stock
Suparma Tbk PT AAQS→
Suparma Tbk PT Stock
Suparma Tbk PT Employees→
Suparma Tbk PT Stock
Suparma Tbk PT ROE→
Suparma Tbk PT Stock
Suparma Tbk PT ROA→
Suparma Tbk PT Stock
Suparma Tbk PT ROCE→
Suparma Tbk PT Stock
Suparma Tbk PT News→
Suparma Tbk PT Stock
Suparma Tbk PT Analyst Price Targets→

Commodities Stocks

Super Crop SafeSunvic Technology CoSuper Dragon Technology CoSunstone MetalsSuper-Dragon Engineering Plastics CoSunstone Development CoSuperbag CoSunshine MetalsSuperior Industrial EnterprisesSunshield ChemicalsSuperior Mining InternationalSunrise Resources PlcAll Stocks A–Z →